Excerpts

Although anemia appeared more frequently in IBD groups, this difference did not reach statistical significance ( p = 0.05).

A near-significant difference in time since the cardiovascular event (39.41 vs. 34.94 days, p = 0.05) was observed between DM and non-DM patients ( Table 1 ).

The results indicated a borderline significant association between RA and the occurrence of MI within six months, with a pooled RR of 1.31 (95% CI 1.00–1.72, p = 0.05), along with low heterogeneity (I 2 = 22.3%, p = 0.26).

Our analysis demonstrated a 32% reduction in sudden cardiac death risk (RR: 0.68 [0.49–0.93], p = 0.02), which closely aligns with Liao et al.’s borderline significant finding of a 33% reduction (RR: 0.67 [0.44–1.01], p = 0.05).

One study reported that IPSS-R outperformed IPSS in predicting OS [ 44 ], with a C-index of 0.74 ( p < 0.001), and showed borderline significant superiority over WPSS ( p = 0.05), although no significant differences were found for PFS prediction.

Additionally, Ki-67 and N-cadherin showed borderline significance ( p ≈ 0.05–0.07), suggesting potential differential expression.

The overall three-group comparison was of borderline significance ( p = 0.050), while pairwise comparisons showed higher OSDI scores in both Group 1 and Group 2 than in controls (both p = 0.034) ( Table 1 ).

A borderline significant difference was observed in initial SOFA scores [8.0 (5.0–10.0) vs. 7.0 (5.0–9.0), p = 0.050], with higher scores among patients who required RRT.

Under conservative Bonferroni correction (α = 0.0033), the NLR–dyspnea ( p = 0.001) and MUST–appetite loss ( p = 0.001) associations remained statistically significant; the NLR–physical functioning, NLR–role functioning, and MUST–nausea/vomiting associations were nominally significant ( p < 0.05) but did not survive Bonferroni correction and are reported as exploratory.

In these adjusted analyses, the higher prevalence of malignancy in cLP-only patients remained significant compared with oLP-only patients (adjusted OR 2.70, 95% CI 1.45–5.04; p = 0.002) and LPP-only patients (adjusted OR 1.88, 95% CI 1.07–3.31; p = 0.028), with borderline significance compared with gLP-only patients (adjusted OR 2.71, 95% CI 1.00–7.35; p = 0.050).

Within macula-on patients, there was a borderline significant increase over time (0.011 [0.00005; 0.022], p = 0.050).

There were significant correlations between BMI reduction and increase of SDNN-I (r = 0.281, p = 0.04; Figure 2 ) and also nearly significant correlations for increase of SDNN (r = 0.267, p = 0.05) and SDANN (r = 0.256, p = 0.07).

End-effector robots (n = 6) showed significant improvement (SMD = 0.30, 95% CI: 0.03–0.58, p = 0.030, I 2 = 0%), while exoskeletons showed a trend (SMD = 0.72, 95% CI: −0.01 to 1.45, p = 0.050, I 2 = 78%) ( Figure 3 B). 3.4.3.

After the adjustment, a clear trend was observed ( p < 0.05) in which higher back extensor strength was associated with increased AMM (r = 1.12) and BMM (r = 0.89).

While the age groups < 25 years, 30– < 35 years, and 35– < 40 years showed a positive trend in the linear regression model with time as an independent variable, none of the age groups showed statistical significance (all p -values > 0.05).

This difference showed borderline significance (χ 2 (1, n =79) = 3.97, p = 0.05).

Two other criteria showed compliance improvements very close to statistical significance ( p = 0.05), i.e., the request for hemorrhage panels from the clinical laboratory, including fibrinogen measures, and the administration of blood derivatives to achieve an FFP:pRBC ratio ≥ 1:2.

A marked difference emerged in blocks 3 and 4, with OP2 requiring longer procedures (borderline significance at block 3, p = 0.05; block 4, p = 0.08).

However, HDL cholesterol (OR = 2.511, 95% CI: 0.992–6.358, p = 0.052), systolic blood pressure (OR = 0.490, 95% CI: 0.227–1.058, p = 0.069), diastolic blood pressure (OR = 0.445, 95% CI: 0.177–1.118, p = 0.085), and fasting glucose (OR = 1.985, 95% CI: 0.449–8.771, p = 0.366) did not reach statistical significance at p < 0.05, indicating the limited predictive power for WHR in this model.

Sensitivity analysis resulted in a borderline non-significant pooled effect (MD = 0.53 min, 95% CI 0.00–1.05, p = 0.05; I 2 = 95%) ( Figure 11 ), suggesting that the primary finding lacks robustness and remains affected by considerable heterogeneity.

However, willingness to reuse the catheter system showed a favorable trend in Group 2, reaching borderline significance in a pairwise comparison with the control group ( p = 0.050) ( Figure 3 ).

Importantly, the Charlson Comorbidity Index showed a borderline significant association with longer antibiotic duration (β = 4.57, 95% CI: −0.05 to 9.20, p = 0.05). 3.6.

The GAM analysis for sleep yielded the most robust explanatory power, explaining 48.7% of the deviance with a highly significant nonlinear relationship (edf: 1.993, F: 122.9, p < 0.05). 3.5.

However, when compared with patients without psoriatic arthritis, the difference in platelet reactivity was not significant, although a clear trend was visible (82% vs. 74%; p > 0.05).

To broaden our search, we also decided to include and describe results with p values that were borderline significant, i.e. 0.10 > p > 0.05.